Literature DB >> 11083624

Candidacidal activities of human lactoferrin peptides derived from the N terminus.

A Lupetti1, A Paulusma-Annema, M M Welling, S Senesi, J T van Dissel, P H Nibbering.   

Abstract

In light of the need for new antifungal agents, the candidacidal activities of human lactoferrin (hLF) and synthetic peptides representing the first, hLF(1-11), and second, hLF(21-31), cationic domains of its N terminus were compared. The results revealed that hLF(1-11) was more effective in killing fluconazole-resistant Candida albicans than hLF(21-31) and much more effective than lactoferrin, as determined microbiologically and by propidium iodide (PI) staining. By using hLF(1-11) and various derivatives, it was found that the second and third residues of the N terminus of hLF(1-11) were critical for its candidacidal activity. Detailed investigation to elucidate the mechanism of action of hLF(1-11) revealed a dose-dependent release of ATP by Candida upon exposure to hLF(1-11). Our observations that sodium azide reduced the PI uptake and candidacidal activity of hLF(1-11) and that, upon exposure to hLF(1-11), the fluorescent dye rhodamine 123 first accumulated inside the mitochondria and later was released into the cytoplasm indicate that the peptide triggers the energized mitochondrion. Furthermore, oxidized ATP, which interferes with the interaction of ATP with its extracellular receptors, blocked the candidacidal action of hLF(1-11), as measured microbiologically and by PI staining. Addition of ATP (or analogues) was not a sufficient stimulus to kill C. albicans or to act synergistically with suboptimal concentrations of the peptide. The main conclusions are that the first two arginines at the N terminus of hLF are critical in the candidacidal activity of hLF(1-11) and that extracellular ATP is essential but not sufficient for the peptide to exert its candidacidal activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083624      PMCID: PMC90189          DOI: 10.1128/AAC.44.12.3257-3263.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  43 in total

Review 1.  Mitochondria and cell death. Mechanistic aspects and methodological issues.

Authors:  P Bernardi; L Scorrano; R Colonna; V Petronilli; F Di Lisa
Journal:  Eur J Biochem       Date:  1999-09

Review 2.  Structure and biological actions of lactoferrin.

Authors:  J H Nuijens; P H van Berkel; F L Schanbacher
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-07       Impact factor: 2.673

3.  Factors affecting the susceptibility of staphylococci to killing by the cationic proteins from rabbit polymorphonuclear leucocytes: the effects of alteration of cellular energetics and of various iron compounds.

Authors:  E Walton; G P Gladstone
Journal:  Br J Exp Pathol       Date:  1976-10

4.  Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations.

Authors:  M M Welling; A Paulusma-Annema; H S Balter; E K Pauwels; P H Nibbering
Journal:  Eur J Nucl Med       Date:  2000-03

5.  Azide inhibition of mitochondrial electron transport. I. The aerobic steady state of succinate oxidation.

Authors:  D F Wilson; B Chance
Journal:  Biochim Biophys Acta       Date:  1967-05-09

6.  Localization of mitochondria in living cells with rhodamine 123.

Authors:  L V Johnson; M L Walsh; L B Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

7.  Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide.

Authors:  G H Zhang; D M Mann; C M Tsai
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

8.  The cellular target of histatin 5 on Candida albicans is the energized mitochondrion.

Authors:  E J Helmerhorst; P Breeuwer; W van't Hof; E Walgreen-Weterings; L C Oomen; E C Veerman; A V Amerongen; T Abee
Journal:  J Biol Chem       Date:  1999-03-12       Impact factor: 5.157

9.  Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier.

Authors:  C Fillebeen; L Descamps; M P Dehouck; L Fenart; M Benaïssa; G Spik; R Cecchelli; A Pierce
Journal:  J Biol Chem       Date:  1999-03-12       Impact factor: 5.157

Review 10.  The significance of iron in infection.

Authors:  J J Bullen
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec
View more
  39 in total

1.  Iron acquisition from transferrin by Candida albicans depends on the reductive pathway.

Authors:  Simon A B Knight; Gaston Vilaire; Emmanuel Lesuisse; Andrew Dancis
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Comparable efficacies of the antimicrobial peptide human lactoferrin 1-11 and gentamicin in a chronic methicillin-resistant Staphylococcus aureus osteomyelitis model.

Authors:  Christopher Faber; Hein P Stallmann; D M Lyaruu; Uwe Joosten; Christof von Eiff; Arie van Nieuw Amerongen; Paul I J M Wuisman
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

3.  Distinct antifungal mechanisms: beta-defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cysteine-free cationic peptides.

Authors:  Slavena Vylkova; Xuewei S Li; Jennifer C Berner; Mira Edgerton
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

Review 4.  Interplay between Candida albicans and the antimicrobial peptide armory.

Authors:  Marc Swidergall; Joachim F Ernst
Journal:  Eukaryot Cell       Date:  2014-06-20

5.  Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption.

Authors:  Slavena Vylkova; Namrata Nayyar; Wansheng Li; Mira Edgerton
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

6.  Human antimicrobial peptides' antifungal activity against Aspergillus fumigatus.

Authors:  A Lupetti; J T van Dissel; C P J M Brouwer; P H Nibbering
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-20       Impact factor: 3.267

7.  Antimicrobial peptide hLF1-11 directs granulocyte-macrophage colony-stimulating factor-driven monocyte differentiation toward macrophages with enhanced recognition and clearance of pathogens.

Authors:  Anne M van der Does; Sylvia J P Bogaards; Bep Ravensbergen; Henry Beekhuizen; Jaap T van Dissel; Peter H Nibbering
Journal:  Antimicrob Agents Chemother       Date:  2009-11-23       Impact factor: 5.191

8.  Candidacidal activity of synthetic peptides based on the antimicrobial domain of the neutrophil-derived protein, CAP37.

Authors:  H Anne Pereira; Irina Tsyshevskaya-Hoover; Heather Hinsley; Sreemathi Logan; Melissa Nguyen; Thuy-Trang Nguyen; Jan Pohl; Karen Wozniak; Paul L Fidel
Journal:  Med Mycol       Date:  2010-03       Impact factor: 4.076

9.  Harnessing biomolecules for bioinspired dental biomaterials.

Authors:  Nicholas G Fischer; Eliseu A Münchow; Candan Tamerler; Marco C Bottino; Conrado Aparicio
Journal:  J Mater Chem B       Date:  2020-08-04       Impact factor: 6.331

10.  Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11).

Authors:  Walter J F M van der Velden; Thijs M P van Iersel; Nicole M A Blijlevens; J Peter Donnelly
Journal:  BMC Med       Date:  2009-09-08       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.